Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 2Uveal Melanoma 1Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1

Interventions

tremelimumab 3durvalumab 3Ipilimumab 3pembrolizumab 2Nivolumab 2Carboplatin 2poly ICLC 1osimertinib 1lenvatinib 1cemiplimab 1Vascular Endothelial Growth Factor A 1Vaccination 1Peptides 1Pemetrexed 1Paclitaxel 1Monophenol Monooxygenase 1Melphalan 1Docetaxel 1Axitinib 1Antibodies, Bispecific 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Diabetes Mellitus, Insulin-Dependent, 12 × Monophenol Monooxygenase × Clear all
NCT00028431 2014-05-22

Novel Adjuvants for Peptide-Based Melanoma Vaccines

University of Southern California

Phase 1 Completed
19 enrolled
Dermatologic

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡